Creatine kinase 2 mass measurement: methods comparison and study of the matrix effect

Clinica Chimica Acta

Volumn 288, Issue 1-2, 1999, Pages 111-119

  Sánchez, Maribel ^a   Canalias, Francesca ^a   Palencia, Teresa ^b   Gella, F Javier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Universitària de Bellvitge ^*  (Spain)

Author keywords

Commutability; Immunoassays comparison; Mass concentration; Matrix effect

Indexed keywords

CREATINE KINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; HEART; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT; PLASMA; PRIORITY JOURNAL; REGRESSION ANALYSIS;

CALIBRATION; CREATINE KINASE; HUMANS; IMMUNOASSAY;

EID: 0344500766     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00149-7     Document Type: Article

References (17)

1. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is the MB creatine kinase the choice for the 1990s? Circulation 1993;88:750-63.
2. Hamm CW. New serum markers for acute myocardial infarction. New Engl J Med 1994;331:607-8.
3. Marshall T, Williams J, Williams KM. Electrophoresis of serum isoenzymes and proteins following acute myocardial infarction. J Chromatogr 1991;569:323-45.
4. Neumeier D, Prellwitz W, Würzburg U et al. Determination of creatine kinase isoenzyme MB activity in serum using immunological inhibition of creatine kinase M subunit activity. Clin Chim Acta 1978;73:445-51.
5. Panteghini M. Diagnostic application of CK-MB mass determination. Clin Chim Acta 1998;272:23-31.
6. de Winter RJ, Koster RW, van Straalen JP, Gorgels JPMC, Hoek FJ, Sanders GT. Critical difference between serial measurements of CK-MB mass to detect myocardial damage. Clin Chem 1997;43:338-43.
7. Gadsden RH, Papadea CN, Cate JC. Analytical evaluation of methods for serum creatine kinase-MB. Electrophoresis, immunoinhibition and solid phase separation. An Clin Lab Sci 1994;24:110-20.
8. Henderson AR, Krishnan S, Webb S, Cheung CM, Nazir DJ, Richardson H. Proficiency testing of creatine kinase and creatine kinase-2: The experience of the Ontario Laboratory Proficiency Testing Program. Clin Chem 1998;44:124-33.
9. Green S, Onoroski M, Moore R, Wu A, Lehrer M, Vaidya H. Use of proposed CK-MB standardization material for calibration of mass measurements: Clinical correlation of patient sera (Abstract). Clin Chem 1993;39:1269.
10. Vaidya H, Apple F, Boches F et al. Preparation of preliminary standards for creatine kinase-MB (CKMB) mass immunoassay (Abstract). Clin Chem 1993;39:1256.
11. Green S, Onoroski M, Moore R, Wu A, Lehrer M, Vaidya H. AACC CK-MB mass assay standardization subcommittee. Standardization of CK-MB mass immunoassays. Clin Chem 1994;40:1032, Abstract.
12. Mao GD, Adeli K, Eisenbrey AB, Artiss JD. Clinical laboratory investigation of the Sanofi ACCESS CK-MB procedure and comparison to electrophoresis and Abbott IMx. Am J Clin Pathol 1996;106:112-7.
13. Gella FJ, Frey E, Ceriotti F et al. Production and certification of an enzyme reference material for creatine kinase isoenzyme 2 (CRM 608). Clin Chim Acta 1998;276:35-52.
14. Ritter CS, Mumm SR, Roberts R. Improved radioimmunoassay for creatine kinase isoenzymes in plasma. Clin Chem 1981;27:1878-87.
15. Hørder M, Elser RC, Gerhardt W, Mathieu M, Sampson EJ. IFCC methods for the measurement of catalytic concentration of enzymes, Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2 IFCC recommendation). Eur J Clin Chem Clin Biochem 1994;32:639-55.
16. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709-20.
17. McBride JH, Rodgerson DO, Ota MK, Maruya M, McEveney S. Creatine kinase MB measured by fluorometric enzyme immunoassay and immunochemiluminescence. An Clin Lab Sc 1991;21:284-90.